Functional hypothalamic amenorrhea, although rare in adolescents prior to onset of menses, is caused by excessive emotional stress, frequent exercise, significant weight loss and/or eating disorders, malnutrition, and chronic disease, such as type 1 diabetes, End stage renal disease, or HIV.

Hypogonadism is a condition in which the male testes or the female ovaries produce little or no sex hormones. Hypogonadotropic hypogonadism (HH) is a form of hypogonadism that is due to a problem with the pituitary gland or hypothalamus.

Exercising too much, eating too little, and being under too much stress can lead to metabolic and hormonal problems — including the hypothalamus releasing too little GnRH in the condition known as functional hypothalamic amenorrhea (FHA).

: a deficiency of estrogen in the body long-term administration of a gonadotropin-releasing hormone agonist induces hypoestrogenism and amenorrhea— B. D.

Overall, there is an excellent chance in achieving a pregnancy for women with hypogonadotropic hypogonadism.

Hypergonadotropic hypogonadism (HH), also known as primary or peripheral/gonadal hypogonadism, is a condition which is characterized by hypogonadism due to an impaired response of the gonads to the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and in turn a lack of sex steroid …

In most cases, hypogonadism can be treated effectively with HRT. This treatment consists of taking medications containing the hormone that your body is lacking, such as testosterone, estrogen and progesterone, or pituitary hormones to replace the ones that the body no longer produces.

Symptoms of hypothalamic amenorrhea include: Missed period(s) or very light bleeding during menstruation. Low libido. Feeling cold often. Depression and anxiety.

Male hypogonadotropic hypogonadism (MHH), a disorder associated with infertility, is treated with testosterone replacement therapy (TRT) and/or gonadotropins replacement therapy (GRT) (TRT and GRT, together with HRT hormone replacement therapy).

Congenital hypogonadotropic hypogonadism is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism).

The clinical characteristics of hypogonadotropic hypogonadism are androgen deficiency and a lack/delay/stop of pubertal sexual maturation. Low blood testosterone levels and low pituitary hormone levels confirm the hypogonadotropic hypogonadism diagnosis. A prolonged stimulated intravenous GnRH test can be useful.

Hypogonadotropic hypogonadism (HH) is a form of hypogonadism that is due to a problem with the pituitary gland or hypothalamus. HH is caused by a lack of hormones that normally stimulate the ovaries or testes. These hormones include gonadotropin-releasing hormone (GnRH), follicle stimulating hormone (FSH) and luteinizing hormone (LH).

Therapy for hypogonadotropic hypogonadism depends on the patient’s desire for future fertility. Hormone replacement with testosterone is the classic treatment for hypogonadism.